From: Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
33RGD -(as) | CGGGATCCTGCTTCGGCCTCAGCGCGC |
33RGD -(s) | CGGGATCCGCCGCGGCAATGCAGCC |
43RGD -(as) | CGGGATCCGGCAGCTTCGGCCGCTG |
43RGD -(a) | CGGGATCCAACTCCAACGCGGCAGCC |
53RGD -(as) | CGGGATCCTTGCGCAGCGGGGGC |
53RGD -(a) | CGGGATCCAGCGGCGCGGAAGAGAACTC |
63RGD -(as) | CGGGATCCCTTCTCGACCTCGGGTTGCG |
63RGD -(a) | CGGGATCCAGCAACAGCAGTGGCAGCG |
73RGD -(as) | CGGGATCCCGGTTTCTTCTGAGGCTTCTCG |
73RGD -(a) | CGGGATCCGGTGGCGCAGGCGG |
83RGD -(as) | CGGGATCCCAGGGGTTTGATCACCGGTTT |
83RGD -(a) | CGGGATCCACCGAACAGGGCGGGG |
3'HVR5-(as) | GGCATGTAAGAAATATGAGTGTCTGGG |
5'HVR2-(s) | CTCACGTATTTGGGCAGGCGCC |